2019
DOI: 10.14744/anatoljcardiol.2019.42247
|View full text |Cite
|
Sign up to set email alerts
|

Turkish Society of Cardiology Consensus Paper onThe Rational Use of Cardiac Troponins in Daily Practice

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
3

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 134 publications
(156 reference statements)
0
2
0
Order By: Relevance
“…There are commercially developed antibody assays specific for cTnT and cTnI, but such assays have not been developed for cTnC due to lack of cardiac specificity 42 . It is important to note that there is misunderstanding that troponin elevation is secondary only to myocyte injury and necrosis But elevated cTn has been observed in many other clinical conditions 24,26,43,44,45 .…”
Section: Troponinmentioning
confidence: 99%
“…There are commercially developed antibody assays specific for cTnT and cTnI, but such assays have not been developed for cTnC due to lack of cardiac specificity 42 . It is important to note that there is misunderstanding that troponin elevation is secondary only to myocyte injury and necrosis But elevated cTn has been observed in many other clinical conditions 24,26,43,44,45 .…”
Section: Troponinmentioning
confidence: 99%
“…Hence, cases vith myocarditis should be followed up with supportive therapies and should be closely monitored for development of heart failure and arrhythmias. In progressive disease despite heart failure therapies and in patients with fulminant myocarditis which developt end organ failure, there are case reports on the usage of myocardial assist devices and extracorporeal membrane oxygenation (3)(4)(5)(6)(7)(8). There is no doubt that further multidisciplinary trials are needed regarding relationship between COVID-19 and myocarditis.…”
mentioning
confidence: 99%